Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer
- PMID: 19864950
- DOI: 10.1097/CCO.0b013e328333ac97
Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer
Abstract
Purpose of review: Differentiated thyroid cancer (DTC), with a rapidly increasing incidence is the most common endocrine malignancy, but with generally favorable survival. Total thyroidectomy with 'therapeutic' cervical lymph node dissection for involved lymph nodes is the standard of care. A more controversial topic is whether routine 'prophylactic' central lymph node dissection (CLND) in patients without evidence of lymph node metastasis should be performed in patients with DTC, as suggested by several recent management guidelines.
Recent findings: A number of retrospective studies suggest that regional lymph node metastases are associated with tumor recurrence and adverse survival. CLND is associated with a higher rate of postoperative athyroglobulinemia and may modify the indications for radioactive iodine treatment. Current guidelines from the American Thyroid Association suggest that prophylactic CLND may be performed for papillary thyroid cancer, especially for advanced tumors (T3 and T4).
Summary: Recent studies and the arguments for and against prophylactic CLND are reviewed. There is currently a trend toward more aggressive surgical therapy, including prophylactic CLND and avoidance of radioactive iodine treatment for DTC, when appropriate. Randomized prospective controlled trials are lacking at this point to determine the role of prophylactic CLND in the management of DTC.
Similar articles
-
Differentiated thyroid cancer: role of the lymph node dissection.G Chir. 2010 Jun-Jul;31(6-7):293-5. G Chir. 2010. PMID: 20646374
-
Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?Surgery. 2009 May;145(5):514-8. doi: 10.1016/j.surg.2009.01.013. Epub 2009 Mar 27. Surgery. 2009. PMID: 19375610
-
Routine bilateral central lymph node clearance for papillary thyroid cancer.Surgery. 2009 Oct;146(4):696-703; discussion 703-5. doi: 10.1016/j.surg.2009.06.046. Surgery. 2009. PMID: 19789029
-
Cervical lymph node dissection in papillary thyroid cancer: current trends, persisting controversies, and unclarified uncertainties.Surg Oncol. 2010 Jun;19(2):e57-70. doi: 10.1016/j.suronc.2009.04.002. Epub 2009 May 17. Surg Oncol. 2010. PMID: 19447608 Review.
-
Surgery of lymph nodes in papillary thyroid cancer.Expert Rev Anticancer Ther. 2006 Sep;6(9):1217-29. doi: 10.1586/14737140.6.9.1217. Expert Rev Anticancer Ther. 2006. PMID: 17020456 Review.
Cited by
-
Can intraoperative frozen section influence the extension of central neck dissection in cN0 papillary thyroid carcinoma?Langenbecks Arch Surg. 2013 Mar;398(3):383-8. doi: 10.1007/s00423-012-1036-3. Epub 2012 Dec 4. Langenbecks Arch Surg. 2013. PMID: 23207498
-
Carbon nanoparticles guide contralateral central neck dissection in patients with papillary thyroid cancer.Oncol Lett. 2018 Jul;16(1):447-452. doi: 10.3892/ol.2018.8691. Epub 2018 May 10. Oncol Lett. 2018. PMID: 29963128 Free PMC article.
-
Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.Endocrine. 2018 Oct;62(1):64-70. doi: 10.1007/s12020-018-1607-3. Epub 2018 May 16. Endocrine. 2018. PMID: 29770933
-
Short and Long-Term Potential Role of Carbon Nanoparticles in Total Thyroidectomy with Central Lymph Node Dissection.Sci Rep. 2018 Aug 9;8(1):11936. doi: 10.1038/s41598-018-30299-8. Sci Rep. 2018. PMID: 30093623 Free PMC article.
-
Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma.World J Clin Cases. 2020 Apr 26;8(8):1350-1360. doi: 10.12998/wjcc.v8.i8.1350. World J Clin Cases. 2020. PMID: 32368529 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials